Biochemists at the University of California San Diego have uncovered patterns in the outer protein coat of group A Streptococcus that could finally lead to a vaccine against this highly infectious bacteria—responsible for more than 500,000 deaths a year, including toxic shock syndrome and necrotizing fasciitis or “flesh-eating disease.”
For the third year in a row, the mystartupXX accelerator program, a UC San Diego-wide program started as a collaboration of the California Institute for Innovation and Development at the Rady School of Management at UC San Diego and the UC San Diego Jacobs School of Engineering in 2012, has been chosen as one of the winners of the national Growth Accelerator Fund competition and recipient of a $50,000 award from the U.S. Small Business Administration (SBA).
Todd Hylton, a well-known San Diego scientist and entrepreneur, is joining the University of California San Diego to become the executive director of the UC San Diego Contextual Robotics Institute. Since 2012, Hylton served as executive vice president of strategy and research at Brain Corporation, a San Diego-based robotics startup. Prior to Brain Corp., Hylton launched a series of successful projects as a program manager at DARPA, including a multi-million dollar effort to develop a chip inspired by the function of biological nervous systems.
J. Andrew McCammon, a distinguished professor of chemistry, biochemistry and pharmacology at the University of California San Diego, has won this year’s most prestigious university-based prize in theoretical chemistry.
Roger Tsien, PhD, co-winner of the 2008 Nobel Prize in chemistry and professor of pharmacology, chemistry and biochemistry at University of California San Diego School of Medicine for 27 years, died August 24 in Eugene, Ore. He was 64.
Researchers at the University of California San Diego have discovered an easy and efficient way to coax human pluripotent stem cells to regenerate bone tissue—by feeding them adenosine, a naturally occurring molecule in the body. The stem-cell-derived bone tissue helped repair cranial bone defects in mice without developing tumors or causing infection.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
